These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 27440047)
1. IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity. Sayedyahossein S; Li Z; Hedman AC; Morgan CJ; Sacks DB J Biol Chem; 2016 Sep; 291(37):19261-73. PubMed ID: 27440047 [TBL] [Abstract][Full Text] [Related]
2. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity. Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865 [TBL] [Abstract][Full Text] [Related]
3. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner. Marikawa Y; Alarcon VB Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288 [TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell. Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201 [TBL] [Abstract][Full Text] [Related]
5. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140 [TBL] [Abstract][Full Text] [Related]
6. Bile acids activate YAP to promote liver carcinogenesis. Anakk S; Bhosale M; Schmidt VA; Johnson RL; Finegold MJ; Moore DD Cell Rep; 2013 Nov; 5(4):1060-9. PubMed ID: 24268772 [TBL] [Abstract][Full Text] [Related]
7. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein. Li C; Srivastava RK; Elmets CA; Afaq F; Athar M Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117 [TBL] [Abstract][Full Text] [Related]
8. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596 [TBL] [Abstract][Full Text] [Related]
9. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985 [TBL] [Abstract][Full Text] [Related]
10. Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells. Pijuan-Galitó S; Tamm C; Annerén C J Biol Chem; 2014 Nov; 289(48):33492-502. PubMed ID: 25301940 [TBL] [Abstract][Full Text] [Related]
11. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099 [TBL] [Abstract][Full Text] [Related]
12. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells. Li X; Zhao X; Su X; Wen J; Yang S; Qin Y; Yan S; Yao Y; Li X; Wang X Arch Biochem Biophys; 2024 Aug; 758():110064. PubMed ID: 38897534 [TBL] [Abstract][Full Text] [Related]
13. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750 [TBL] [Abstract][Full Text] [Related]
14. BMP2-SMAD signaling represses the proliferation of embryonic neural stem cells through YAP. Yao M; Wang Y; Zhang P; Chen H; Xu Z; Jiao J; Yuan Z J Neurosci; 2014 Sep; 34(36):12039-48. PubMed ID: 25186749 [TBL] [Abstract][Full Text] [Related]
15. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ. Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584 [TBL] [Abstract][Full Text] [Related]
16. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides. Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421 [TBL] [Abstract][Full Text] [Related]
17. Angiomotin'g YAP into the nucleus for cell proliferation and cancer development. Hong W Sci Signal; 2013 Sep; 6(291):pe27. PubMed ID: 24003252 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Kim M; Kim T; Johnson RL; Lim DS Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714 [TBL] [Abstract][Full Text] [Related]
19. IQGAP1 binds to estrogen receptor-α and modulates its function. Erdemir HH; Li Z; Sacks DB J Biol Chem; 2014 Mar; 289(13):9100-12. PubMed ID: 24550401 [TBL] [Abstract][Full Text] [Related]
20. YAP/TAZ for cancer therapy: opportunities and challenges (review). Guo L; Teng L Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]